Skip to Content
Merck

Transport of L-arginine and nitric oxide formation in human platelets.

European journal of biochemistry (2003-04-24)
Maria G Signorello, Raffaele Pascale, Giuliana Leoncini
ABSTRACT

The results of the present study show that human platelets take up l-arginine by two transport systems which are compatible with the systems y+ and y+L. These Na+independent transporters have been distinguished by treating platelets with N-ethylmaleimide that blocks selectively system y+. System y+, that accounts for 30-40% of the total transport, is characterized by low affinity for l-arginine, is unaffected by l-leucine, is sensitive to changes of membrane potential and to trans-stimulation. The other component of l-arginine transport identified with the system y+L (approximately 60-70% of the total flux) shows high affinity for l-arginine, is insensitive to N-ethylmaleimide treatment, unaffected by changes in membrane potential, sensitive to trans-stimulation and inhibited by l-leucine in the presence of Na+. Moreover a strict correlation between l-arginine transport and nitric oxide (NO) production in whole cells was found. N-ethylmaleimide and l-leucine decreased NO production as well as cGMP elevation, and the effect on NO and cGMP were closely related. It is likely that the l-arginine transport systems y+ and y+L are both involved in supplying substrate for NO production and regulation in human platelets.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tetrapentylammonium hydroxide solution, ~20% in H2O (T)
Sigma-Aldrich
Tetrapentylammonium bromide, ≥99%
Supelco
Tetrapentylammonium bromide, suitable for ion pair chromatography, LiChropur, ≥99.0% (AT)